Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ballantyne

Showing results (591-600 of 999) with videos related to

Pageof 100
Sort By:
The American Journal of Cardiology|November 4, 2020
Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery DiseaseOlga A Gimnich, Jonathan Holbrook, Tatiana Belousova, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2014
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) studyRon C Hoogeveen, John W Gaubatz, Wensheng Sun, et al.
Journal of the American Heart Association|August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD RegistrySuzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
Journal of the American College of Cardiology|January 20, 2010
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) studyEric Y Yang, Vijay Nambi, Zhengzheng Tang, et al.
Scientific Reports|December 29, 2019
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomesEric Y Yang, Mohammad A Khan, Edward A Graviss, et al.
Cardiovascular Drugs and Therapy|September 4, 2020
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare SystemAkash Kataruka, Dhruv Mahtta, Julia M Akeroyd, et al.
Diabetes Care|August 5, 2010
A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) studyL Maria Belalcazar, David M Reboussin, Steven M Haffner, et al.
Diabetes Care|May 15, 2015
Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEADL Maria Belalcazar, Wei Lang, Steven M Haffner, et al.
Diabetes Research and Clinical Practice|November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) studyMagnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.
Clinical Rheumatology|June 3, 2017
Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis InitiativeGrace H Lo, Timothy E McAlindon, Jeffrey N Katz, et al.
Pageof 100

Showing results (591-600 of 999) with videos related to

Sort By:
Pageof 100
The American Journal of Cardiology|November 4, 2020
Relation of Magnetic Resonance Imaging Based Arterial Signal Enhancement to Markers of Peripheral Artery DiseaseOlga A Gimnich, Jonathan Holbrook, Tatiana Belousova, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 22, 2014
Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) studyRon C Hoogeveen, John W Gaubatz, Wensheng Sun, et al.
Journal of the American Heart Association|August 9, 2021
What Do US Physicians and Patients Think About Lipid-Lowering Therapy and Goals of Treatment? Results From the GOULD RegistrySuzanne V Arnold, Christopher P Cannon, James A de Lemos, et al.
Journal of the American College of Cardiology|January 20, 2010
Clinical implications of JUPITER (Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin) in a U.S. population insights from the ARIC (Atherosclerosis Risk in Communities) studyEric Y Yang, Vijay Nambi, Zhengzheng Tang, et al.
Scientific Reports|December 29, 2019
Relationship of extracellular volume assessed on cardiac magnetic resonance and serum cardiac troponins and natriuretic peptides with heart failure outcomesEric Y Yang, Mohammad A Khan, Edward A Graviss, et al.
Cardiovascular Drugs and Therapy|September 4, 2020
Eligibility for Low-Dose Rivaroxaban Based on the COMPASS Trial: Insights from the Veterans Affairs Healthcare SystemAkash Kataruka, Dhruv Mahtta, Julia M Akeroyd, et al.
Diabetes Care|August 5, 2010
A 1-year lifestyle intervention for weight loss in individuals with type 2 diabetes reduces high C-reactive protein levels and identifies metabolic predictors of change: from the Look AHEAD (Action for Health in Diabetes) studyL Maria Belalcazar, David M Reboussin, Steven M Haffner, et al.
Diabetes Care|May 15, 2015
Improving Adiponectin Levels in Individuals With Diabetes and Obesity: Insights From Look AHEADL Maria Belalcazar, Wei Lang, Steven M Haffner, et al.
Diabetes Research and Clinical Practice|November 21, 2022
Importance of NT-proBNP and conventional risk factors for prediction of death in older adults with and without diabetes mellitus- A report from the Atherosclerosis Risk in Communities (ARIC) studyMagnus O Wijkman, Brian L Claggett, Marcus V B Malachias, et al.
Clinical Rheumatology|June 3, 2017
Systolic and pulse pressure associate with incident knee osteoarthritis: data from the Osteoarthritis InitiativeGrace H Lo, Timothy E McAlindon, Jeffrey N Katz, et al.
Pageof 100